Beyond Borders: New Research and Leadership at the European Journal of Therapeutics Unveils Global Insights

A Beacon for Medical Innovation

The European Journal of Therapeutics (Eur J Ther) stands at the intersection of regional expertise and global scientific dialogue. As a Q3 journal (Impact Factor: 0.4) in General & Internal Medicine, it bridges emerging research with clinical practice ² ³ . With its latest issue (Vol. 31, No. 3) and a revitalized editorial board, the journal amplifies diverse medical voices—from Türkiye to Brazil—showcasing breakthroughs in vascular interventions, pediatric toxicology, and neuropharmacology.

1. New Editorial Board: A Global Mosaic

The 2025 editorial team reflects strategic international collaboration:

Editor-in-Chief

Şevki Hakan Eren, MD

Emergency Medicine, Gaziantep University, Türkiye, a prolific researcher with work in toxicology and critical care ¹ .

Deputy Editors

Multidisciplinary Team

Experts like Saliha Seda Adanır (Anatomy) and Mehmet Sait Menzilcioğlu (Radiology) ensure multidisciplinary oversight ¹ .

Global Representation

30% of the board hails beyond Türkiye, including:

Ricardo Grillo

Brazil

Oral Surgery

Tsvetoslav Georgiev

Bulgaria

Internal Medicine

Victor Nedzvetsky

Ukraine

Biochemistry

This diversity enriches the journal's scope, particularly in anatomy, pharmacology, and translational medicine ¹ .

2. Spotlight: Featured Research from the June 2025 Issue

Original Article: Outcomes of Carotid Artery Stenting in Near-Occlusion Without Collapse

Study Team: Cingoz, Arslan, Turksayar et al. ³

Background

Carotid near-occlusion—a severe narrowing of arteries supplying the brain—often leads to strokes. Traditional treatments include stenting, but data on near-occlusion without collapse (a rarer subtype) remains scarce. This study compared stenting outcomes between near-occlusion and conventional stenosis patients.

Methodology: Step-by-Step

Patient Selection:
- 142 participants (2019–2024): 71 with near-occlusion, 71 with severe stenosis.
- Groups matched for age, hypertension, and diabetes.
Intervention:
- All patients underwent carotid stenting under local anesthesia.
- Intraoperative heparin anticoagulation and dual antiplatelet therapy (aspirin + clopidogrel) were administered.
Outcome Tracking:
- Primary: Technical success (residual stenosis <30%).
- Secondary: 30-day stroke/death rates, hemodynamic changes.

Table 1: Patient Demographics
Characteristic	Near-Occlusion Group (n=71)	Stenosis Group (n=71)
Mean Age (years)	68.2	66.5
Hypertension (%)	89%	85%
Diabetes (%)	42%	38%
Current Smokers (%)	31%	29%

Results & Implications

Technical Success: Comparable between groups (97% vs. 99%, p=0.21).
Complication Rates: Near-occlusion patients had higher transient ischemic attacks (TIAs) (5.6% vs. 1.4%, p=0.04).
Blood Flow Restoration: Both groups showed similar cerebral perfusion improvement.

Table 2: Key Outcomes
Outcome	Near-Occlusion Group	Stenosis Group	p-value
Technical Success (%)	97%	99%	0.21
30-Day Stroke/Death (%)	2.8%	1.4%	0.31
TIA (%)	5.6%	1.4%	0.04

Conclusion

Stenting is viable for near-occlusion but warrants cautious TIA monitoring. This informs stroke guidelines for high-risk subtypes.

3. Journal Evolution: Digital Advancements

Early View Articles

Manuscripts are now published online post-acceptance before print assignment, accelerating dissemination. These are indexed in Web of Science, boosting citation potential ² ³ .

Open Science

All articles use CC BY-NC 4.0 licensing, permitting broad reuse for education and policy ² .

Legacy

Founded in 1990 as the Gaziantep Medical Journal, the journal rebranded in 2017 to reflect its pan-European mission ³ .

4. The Scientist's Toolkit: Key Reagents in Vascular Intervention Research

Critical materials from the featured study and related fields:

Table 3: Research Reagent Solutions
Reagent/Material	Function	Application in Study
Heparin	Anticoagulant	Prevents clot formation during stenting
Dual Antiplatelet Therapy	Inhibits platelet aggregation	Post-op stroke prevention (aspirin + clopidogrel)
Digital Subtraction Angiography (DSA)	Real-time vascular imaging	Guided stent placement accuracy
Transcranial Doppler	Blood flow velocity measurement	Monitored cerebral perfusion post-stent
CT Perfusion Scans	3D blood flow mapping	Assessed tissue viability

5. Looking Ahead: Special Calls & Impact

Upcoming Themes

The journal prioritizes peptide therapeutics (e.g., venom-derived peptides for pain management)
Pediatric pharmacology

Clinical Reach

Studies like the corrosive poisoning analysis in children (Süleyman Nogay et al.) directly shape emergency protocols ³

Reader Engagement

Clinicians can join as reviewers or submit debate pieces on controversies like pulsed-field ablation in cardiology ⁶ .

Conclusion: Bridging Discovery and Practice

The European Journal of Therapeutics leverages its renewed leadership and digital agility to spotlight research that transforms patient care—from carotid interventions to pediatric toxicology. With its global lens and commitment to accessibility, it invites scientists worldwide to join a conversation that starts in Gaziantep and resonates across continents. As Şevki Hakan Eren notes, "Our mission is to make local insights globally relevant." Explore Vol. 31, Issue 3 to witness this mission in action ¹ ³ .